Characteristic | No. (%) | Median Dx Age (yr) | 95% CI | P Value |
---|---|---|---|---|
Overall | 833 | 33.8 | (32.7–35.9) | NA |
Sex | .937 | |||
Female | 425 (51%) | 33.4 | (31.0–35.7) | |
Male | 408 (49%) | 34.3 | (31.5–37.7) | |
Ethnicity | <.001 | |||
Asian/Pacific Islander | 113 (14%) | 29.9 | (25.9–34.3) | |
Black/African American | 56 (5%) | 46.5 | (41.2–50.3) | |
Hispanic | 224 (27%) | 27.0 | (23.4–29.8) | |
Native American | 9 (1%) | 37.1 | (17.4–47.1) | |
Non-Hispanic Caucasian | 431 (52%) | 38.7 | (35.3–42.6) | |
Hemorrhagic presentation | <.001 | |||
Yes | 375 (45%) | 28.7 | (26.6–32.2) | |
No | 458 (55%) | 37.6 | (35.3–40.6) | |
HHT diagnosis | .695 | |||
Yes | 12 (1%) | 38.3 | (1.8–54.0) | |
No | 821 (99%) | 33.7 | (31.6–35.8) |
Note:—Dx indicates diagnosis; NA, not applicable; HHT, hereditary hemorrhagic telangiectasia syndrome.
↵a P values are from log-rank tests of survivor functions.